Company: NGVT
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001653477-25-000108
Chunk: 94

Company: Ingevity Corp
Filing Date: 2025-08-05
Form: 10-Q
Item: Part I, Item 8
Chunk 94
---
0.2)$— Natural gas contracts (1)0.1 (0.8)(0.1)(1.5)Total before tax(0.1)(0.8)(0.3)(1.5)(Provision) benefit for income taxes— 0.2 0.1 0.4 Amount included in net income (loss)$(0.1)$(0.6)$(0.2)$(1.1)_______________(1) Included within "Cost of sales" on the condensed consolidated statements of operations.Share RepurchasesOn July 25, 2022, our Board of Directors authorized the repurchase of up to $500.0 million of our common stock (the "2022 Authorization"), and rescinded the prior outstanding repurchase authorization with respect to the shares that remained unused under the prior authorization. Shares under the 2022 Authorization may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market prevailing conditions and other 

18

INGEVITY CORPORATIONNotes to the Condensed Consolidated Financial StatementsJune 30, 2025(Unaudited)

factors, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.During the three and six months ended June 30, 2025 and 2024, we repurchased no common stock. At June 30, 2025, $353.4 million remained unused under the 2022 Authorization.

Note 11: Restructuring and Other (Income) Charges, net

Detail on the restructuring charges and other (income) charges, net, is provided below.Three Months Ended June 30,Six Months Ended June 30,In millions2025202420252024Restructuring charges$21.9 $10.0 $34.2 $72.3 Other (income) charges, net— 3.1 — 3.6 Total Restructuring and other (income) charges, net$21.9 $13.1 $34.2 $75.9 Restructuring ChargesIn millionsSeverance and other employee-related costsOther charges (income) (1)Asset disposal charges (2)TotalPerformance Chemicals repositioning$— $8.9 $3.3 $12.2 Other (3)